Details of patients with CLL
. | . | . | . | Rai stage splenomegaly . | CLL duration, mo . | Blood counts at sampling . | . | . | Previous therapy . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient . | Sex . | Age, y . | RhD +/- . | . | . | Hb, g/L . | WBC, 109/L . | Plts, 109/L . | . | ||
| 1 | M | 13 | + | 0 | 85 | 108 | 297 | 86 | None | ||
| 2 | F | 26 | + | I | 26 | 143 | 11.2 | 121 | None | ||
| 3 | M | 58 | + | 0 | 21 | 140 | 71.4 | 97 | None | ||
| 4 | M | 22 | + | II | 59 | 163 | 37.3 | 214 | Chlorambucil | ||
| 4fb | |||||||||||
| 5 | M | 31 | + | I | 42 | 149 | 22 | 136 | None | ||
| 6 | F | 67 | + | 0 | 120 | 128 | 29.6 | 197 | None | ||
| 7 | F | 30 | + | 0 | 30 | 132 | 9.7 | 288 | None | ||
| 8 | M | 62 | + | 0 | 82 | UA | 17.6 | 238 | None | ||
| 9 | F | 65 | + | I | 22 | 133 | 53.2 | 338 | None | ||
| 10 | F | 66 | - | 0 | 84 | 143 | 17.3 | 284 | None | ||
. | . | . | . | Rai stage splenomegaly . | CLL duration, mo . | Blood counts at sampling . | . | . | Previous therapy . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient . | Sex . | Age, y . | RhD +/- . | . | . | Hb, g/L . | WBC, 109/L . | Plts, 109/L . | . | ||
| 1 | M | 13 | + | 0 | 85 | 108 | 297 | 86 | None | ||
| 2 | F | 26 | + | I | 26 | 143 | 11.2 | 121 | None | ||
| 3 | M | 58 | + | 0 | 21 | 140 | 71.4 | 97 | None | ||
| 4 | M | 22 | + | II | 59 | 163 | 37.3 | 214 | Chlorambucil | ||
| 4fb | |||||||||||
| 5 | M | 31 | + | I | 42 | 149 | 22 | 136 | None | ||
| 6 | F | 67 | + | 0 | 120 | 128 | 29.6 | 197 | None | ||
| 7 | F | 30 | + | 0 | 30 | 132 | 9.7 | 288 | None | ||
| 8 | M | 62 | + | 0 | 82 | UA | 17.6 | 238 | None | ||
| 9 | F | 65 | + | I | 22 | 133 | 53.2 | 338 | None | ||
| 10 | F | 66 | - | 0 | 84 | 143 | 17.3 | 284 | None | ||
None of the patients listed in the table was receiving current therapy; all were Coombs IgG negative.
Plts indicates platelets; other abbreviations are as for Table 1.